ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  

Found 47 studies with search of:   (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies

Show Display Options  Display Options

1 Recruiting The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A (TB vaccine);   Biological: MVA 85A
2 Recruiting Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
3 Recruiting Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine;   Biological: pneumococcal polysaccharide vaccine
4 Recruiting Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
5 Not yet recruiting Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad5.ENVA.48 HIV-1 vaccine
6 Recruiting Dendritic Cell Vaccine in HIV-1 Infection
Condition: HIV Infections
Intervention: Biological: Dendritic cell vaccine
7 Recruiting Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults
Condition: HIV Infections
Interventions: Biological: pGA2/JS7 DNA;   Biological: Modified vaccinia Ankara/HIV62
8 Recruiting Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent human papillomavirus vaccine
9 Recruiting Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
Intervention: Biological: HIV gp120/NefTat/AS02A Vaccine
10 Recruiting Project UNITY - HIV Risk Reduction and Vaccine Education Interventions
Conditions: HIV Infections;   Hepatitis B
Intervention: Behavioral: Enhanced HIV risk reduction and HIV vaccine education
11 Recruiting Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Condition: HIV Infections
Interventions: Biological: EP-1233;   Biological: MVA-mBN32
12 Recruiting A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
13 Recruiting Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: MVA-CMDR vaccine
14 Recruiting Autologous Dendritic Cell Vaccine in HIV1 Infection
Condition: HIV Infections
Intervention: Biological: Autologous HIV-1 ApB DC Vaccine
15 Recruiting Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
Condition: HIV Infections
Intervention: Device: TriGrid™ Delivery System
16 Recruiting Screening Protocol for HIV Vaccine Studies
Conditions: HIV Seronegativity;   HIV Infections
Intervention:
17 Not yet recruiting Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
18 Recruiting Phase 1 Safety Study of Two Experimental HIV Vaccines
Conditions: AIDS Vaccines;   HIV Infections;   HIV-1
Interventions: Drug: VRC-HIVADV027-00-VP;   Drug: VRC-HIVADV038-00-VP
19 Recruiting Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-1 gag DNA;   Biological: IL-15 DNA adjuvant;   Biological: IL-12 DNA adjuvant
20 Recruiting Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in HIV Infected Females
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Intervention: Biological: GSK Biologicals' HPV vaccine 580299
21 Recruiting Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-Infected Men
Conditions: Anal Cancer;   HIV Infections
Intervention: Biological: Gardasil
22 Not yet recruiting Immune Responses to Pneumococcal Vaccination Among HIV-Infected Subjects.
Condition: HIV Infections
Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
23 Not yet recruiting Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
24 Recruiting Reactogenicity and Immunogenicity of Vaginal ZM96gp140
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome
Interventions: Biological: HIV glycoprotein 140 ZM96 (vaccine);   Biological: Carbopol 974
25 Recruiting Controlling Acute or Early HIV Infection With Antiretroviral Drugs, With or Without a Candidate Vaccine
Condition: HIV Infections
Interventions: Biological: HIV-1 immunogen;   Biological: HIV-1 Immunogen;   Biological: HIV-1 Immunogen
26 Recruiting Screening HIV-Infected Patients for Vaccine Studies
Condition: HIV Infection
Intervention:
27 Recruiting Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults
Condition: HIV Infections
Interventions: Biological: PennVax B;   Biological: IL-12;   Biological: IL-15
28 Recruiting A Phase II Randomized, Open Label, Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)
Condition: HIV Infections
Intervention: Biological: Tat protein
29 Recruiting Safety and Tolerability of and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving Anti-HIV Treatment
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
30 Recruiting Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
Condition: HIV Infection
Intervention: Biological: ADMVA
31 Recruiting A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Conditions: HIV Infections;   TB
Intervention: Biological: MVA 85A
32 Recruiting Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
Conditions: HIV Infections;   Hepatitis C
Interventions: Biological: Twinrix;   Biological: Decavac
33 Recruiting Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
Condition: HIV Infections
Interventions: Biological: IMVAMUNE (MVA-BN);   Biological: IMVAMUNE;   Biological: IMVAMUNE
34 Recruiting Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
Condition: HIV Infections
Intervention: Drug: VRC-HIVADV014-00-VP
35 Not yet recruiting Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Biological: MVA-mBN120B
36 Recruiting Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
Condition: HIV-1
Interventions: Biological: ALVAC-HIV (vCP1521), sanofi pasteur;   Biological: AIDSVAX B/E: Bivalent HIV gp120
37 Recruiting T Cell Vaccination in HIV Infection
Condition: HIV Infections
Intervention: Biological: T cell vaccination
38 Recruiting Influenza Vaccine in HIV
Conditions: Influenza;   HIV
Intervention: Biological: Fluviral
39 Not yet recruiting Thai Prophylactic Vaccine Study
Condition: HIV
Interventions: Biological: a DNA plasmid (pHIS-HIV-AE) encoding the HIV-1 AE antigens, modified Gag, Pol, Tat/Rev and Env;   Biological: a non-replicating, recombinant fowlpox virus (rFPV-HIV-AE) encoding the HIV-1 AE antigens, modified Gag, Pol, Tat/Rev and Env
40 Recruiting Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic pHIS-HIV-AE DNA Prime and rFPV-HIV-AE Boost HIV Vaccination Strategy
Condition: HIV Infections
Interventions: Biological: pHIS-HIV-AE DNA Prime;   Biological: rFPV-HIV-AE Booster;   Biological: Placebo
41 Recruiting A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1
Conditions: Adherence;   Community Outreach;   HIV Risk Behaviors;   Hepatitis A Vaccines;   Hepatitis B Vaccines;   Hepatitis C;   Needle-Exchange Programs;   Substance Abuse, Intravenous
Intervention: Behavioral: Needle-Exchange Programs
42 Recruiting Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
Condition: Precancerous/Nonmalignant Condition
Interventions: Drug: E1M184V peptide vaccine;   Drug: incomplete Freund's adjuvant;   Drug: sargramostim;   Procedure: immunoenzyme technique
43 Not yet recruiting Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Conditions: Cervical Cancer;   Precancerous/Nonmalignant Condition
Interventions: Drug: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Procedure: DNA analysis;   Procedure: colposcopic biopsy;   Procedure: cytology specimen collection procedure;   Procedure: polymerase chain reaction
44 Recruiting DermaVir Patch (LC002) in HIV-1 Infected Treatment-naïve Patients
Condition: HIV Infections
Interventions: Biological: DermaVir Patch;   Biological: DermaVir Placebo;   Biological: DermaVir Patch;   Biological: DermaVir Placebo;   Biological: DermaVir Patch;   Biological: DermaVir Placebo
45 Not yet recruiting A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection
Condition: HIV Infections
Interventions: Biological: MVA-B;   Biological: Placebo
46 Not yet recruiting Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Conditions: Cholera;   Vibrio Infections;   Diarrhea
Interventions: Biological: CholeraGarde®;   Biological: Placebo
47 Recruiting Early Versus Delayed Pneumococcal Vaccination in HIV
Condition: Pneumococcal Infections
Interventions: Biological: Pneumovax or Pneumo23;   Biological: Prevnar

RSS Feed for studies found by your search that were received in the last 14 days  RSS Feed for studies found by your search that were received in the last 14 days  

Show download Options  Download Options




Links to all studies - primarily for crawlers